Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Reach out today to learn how HealthVerity Marketplace can support your team
Methods We performed a retrospective cohort study using TriNetX database to evaluate adult patients who carried the diagnosis of RA from January 1, 2006 to December 1, 2024 with co-existing T2DM and who initiated GLP-1 analogs or DPP4i after diagnosis of RA and T2DM
Trends in Endocrinology & Metabolism , 29(6), 423-435
This falls within established therapeutic ranges and aligns with dosing used in anti-aging applications
PMC 6953387
Ive watched this work in my practice
US$ 20.17
US$ 21.77
US$ 28.48
US$ 28.34
US$ 27.64
US$ 25.12
US$ 22.84
